Center-Specific Survival Analysis
Outcomes reporting in allogeneic HCT is necessary to provide information requested by patients, insurers, and government agencies and to comply with current laws. The SCTOD contract requires CIBMTR to conduct an analysis of one-year survival rates at each transplant center in the US annually. The report generated by CIBMTR is meant to be useful as a quality improvement tool for participating centers.
Additional information about this analysis and data are available.
- A description of the current methodology used in generating this report can be found on CIBMTR's website (previous methodology can also be found on this webpage)
- Many questions are addressed in the FAQs
- The report and additional tools are available to transplant centers through the CIBMTR Portal
- Center Outcomes Forums are held to increase transparency and understanding of center outcomes reporting in HCT
- Webinar describing the Center-Specific Survival Analysis presented by Dr. Douglas Rizzo at the 2025 Tandem Meetings
- Data are made available to the public in the NMDP Transplant Center Directory